TOPICS

Focus on Clinical Trials

 _____________________

7 Reasons to Consider Trials

Other Search by | Call NCI | Tools

About Trials | Expanded Access (Compassionate Use) |
Other Trial Resources | PDQ | Travel Help | Informed Consent

A) Geographic search by State | World 
(CLL | Lymphoma specific)  BY MAP of Study Locations
 
B) See New Trials for lymphoma / CLL
 
C) See Phase III for Indolent / Aggressive 
comparing and advancing the standard of care
 
D) See Gene profiling- / biomarker-based trials for 
Follicular | CLL | DLBCL | Hodgkins | MCL | T-cell | Unspecified
 
E) Help bringing trials to You by Pharmatech
 
F) Search for trials using TrialCheck.org  
(easy to use - by Coalition of Cancer Cooperative Groups)

G) Let us Help You Find Trials email a PAL

H) Trials of interest based on clinical circumstances
First Therapy - Low Toxic  | First Primary Therapy  
Relapsed / Refractory Lymphoma | Other |

I) See Pipeline of new agents with links to clinical trials

J) See NCI-sponsored trials for Lymphoma  Cancer.gov 

K) International Clinical Trial Search by WHO

 

NCI: Which Study Results Are the Most Helpful in Making Cancer Care Decisions?

Accelerated Approval (AA) for Oncology Drug Minutes of  Advisory Meeting:
 http://1.usa.gov/dVkY23  (406 pages.)

NCI Taking Part in Cancer Treatment Research Studies  Cancer.gov | PDF

Oncologists Divided Over Experimental Treatments  Medscape (free login req.) 

The majority of respondents — 61% — said that patients should be discouraged from using  off-protocol treatments. A smaller number — 31% — said they should not be available at all.  More than half the oncologists surveyed said that patients considering trial enrollment should be informed if an investigational therapy is available; 34% disagreed. A total of 26% of respondents thought that patients considering enrollment have a right to off-protocol treatment; 56% said this is not the case.

Survey Reveals Blood Cancer Patients Not Being Directed to Clinical Trials Despite 
Their Importance in Developing New Therapies  prnewswire  

Kornhaber said the findings were troubling because clinical trials are such a crucial step in the
development of new treatments and are often the only remaining hope for patients. 

"For many cancer patients, clinical trials present an opportunity to take advantage of promising new treatments not yet available and may offer new hope for patients when the standard treatments are not effective," Kornhaber said. 

She added that most types of leukemia, lymphoma and myeloma are not curable, yet many promising therapies are being tested in clinical trials to assess if they will delay the progression of disease and/or reduce side effects compared to standard therapies. "

Results of a survey to help understand why cancer patients choose to enter or not to 
enter cancer clinical trials.  actmagazine 

Public Registration of Clinical Trials ~ Robert Steinbrook, M.D.  NEJM 2004

Would a clinical trial be appropriate for me? Questions for your doctor. 
A free printable brochure prepared by Patients Against Lymphoma  PDF 

How to Use and Conduct More Specific ClinicalTrials.gov Searches

Protocol registration system (for drug sponsors)  http://prsinfo.clinicaltrials.gov